GL1X · GenesisL1 explorer

MolNFT v1 · #143190 · protein

MRE11 dimer in complex with endonuclease inhibitor PFM04

6ASC · Nuclease sbccd subunit D: “MRE11 dimer in complex with endonuclease inhibitor PFM04”. X-ray diffraction, 2 ligands (BU7, MN), 6 pockets (best druggability 0.77). MolNFT v1 #143190 on GenesisL1: 3D structure, binding sites and…

PDB
6ASC
Type
protein
Length
652 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclease sbccd subunit D
UniProt
Q9X1X0
Ligands
BU7, MN
Pockets
6 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 27% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclease sbccd subunit Dprotein33126% helix, 27% strandQ9X1X0
BNuclease sbccd subunit Dprotein32127% helix, 28% strandQ9X1X0

Ligands and binding sites

  • BU7 · (5E)-3-butyl-5-[(4-hydroxyphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one · ligand · 2 copies · chains A, B
  • MN · Manganese (II) ion · metal · 4 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15170.770.8466BU7
21940.730.8829BU7
32980.580.7844MN
41060.510.8218empty
51120.500.8119empty

Interfaces

1 interface between chains.

  • A–B · 875 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 6ASC · Mre11 dimer in complex with Endonuclease inhibitor PFM04 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.